Autoencoder Latent Space for Drug-Like Molecule Generation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current drug discovery processes are time-consuming and costly, often requiring years and billions of dollars to identify effective treatments, with existing machine learning techniques being computationally expensive and producing molecules that may be toxic or unsuitable for human use due to high molecular weights, poor solubility, or other characteristics.

Innovation Solution

The implementation of a framework using a variational autoencoder-generated latent space and property prediction by two neural networks in sequence, enabling faster gradient-based reverse-optimization of molecular properties to generate drug-like molecules with high binding affinity while maintaining favorable pharmacologic and chemical properties.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional drug discovery methods are used, then molecules can be identified with affinity for target molecules, but the process is costly and time-consuming

Engineering Contradiction:
Improvemolecule affinityVSAvoiddiscovery time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent replaces traditional mechanical experimental drug discovery methods with a computational system using neural networks and autoencoders. The system encodes molecules into latent space representations and uses property predictors to evaluate molecular properties computationally, eliminating the need for time-consuming physical synthesis and testing cycles while maintaining the ability to identify molecules with target affinity.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent performs preliminary computational screening and optimization of molecular candidates before physical synthesis. By using the trained neural network system to predict properties and optimize molecular structures in silico, the system identifies promising candidates in advance, reducing the time and resources needed for subsequent experimental validation.

Inventive Principle:
Principle #10Preliminary action

2Productivity

If existing machine learning techniques are used to generate molecules, then molecule generation speed can be improved, but the generated molecules may have toxic or unsuitable characteristics

Engineering Contradiction:
Improvemolecule generation speedVSAvoidmolecule suitability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent implements a feedback mechanism where property predictors evaluate generated molecules and provide guidance for optimization. The system uses the predicted properties (including toxicity and suitability metrics) to iteratively refine molecular candidates, ensuring that speed gains do not compromise molecule quality. The feedback loop continues until molecules meet desired property thresholds.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent optimizes multiple molecular parameters simultaneously using the neural network system, including molecular weight, solubility, and toxicity profiles. By adjusting these parameters through computational optimization rather than random generation, the system produces molecules that are both generated quickly and meet suitability criteria for further development.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If computational optimization is performed to improve molecular properties, then binding affinity can be enhanced, but computational cost increases

Engineering Contradiction:
Improvebinding affinityVSAvoidcomputational cost
Core Design Contradiction:
ReliabilityVSUse of energy by moving object

Solution Approach 1:

The patent applies computational optimization selectively to the most promising molecular candidates identified by the autoencoder, rather than optimizing all possible molecules. By focusing computational resources on a subset of high-potential candidates based on initial screening, the system achieves enhanced binding affinity predictions while controlling overall computational cost.

Inventive Principle:
Principle #16Partial or excessive action

Data Source

PatentUS20240005179A1Computational architecture to generate representations of molecules having targeted properties
Publication Date: 2024.01.04 RGT UNIV OF CALIFORNIA
  • US20240005179A1 patent drawing
  • US20240005179A1 patent drawing
  • US20240005179A1 patent drawing

AI summary

Apparatuses, systems, and techniques are described to generate representations of molecules having one or more targeted properties. In one or more examples, an autoencoder can be trained to generate a latent space that represents a number of molecules. The latent space can be used to train a property prediction network that includes a number of property predictors. A latent space optimization process can use the property predictors to identify regions of the latent space that represent molecules having the one or more targeted properties.